Please provide your email address to receive an email when new articles are posted on . Routine, proactive therapeutic drug monitoring for patients receiving biopharmaceuticals for rheumatic and ...

Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...

After the first 6 months of disease-modifying antirheumatic drugs (DMARDs) use in patients with rheumatoid arthritis (RA), most very abnormal results newly seen in long-term routine laboratory ...

Caffeine is widely used in premature infants to treat apnea of prematurity, but the value of routine drug level monitoring is unclear. The authors conducted this retrospective study to evaluate the ...

We piloted a new approach to promote COVID-19 screener adoption for at-risk populations. Our approach enables integration of COVID-19 screening into a chronic disease symptom-monitoring intervention.

HOFFMAN ESTATES, Ill., Aug. 19, 2025 /PRNewswire/ -- Heart health leader OMRON Healthcare today issued a national call-to-action for regular at-home blood pressure monitoring in response to new ...